`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF WEST VIRGINIA
` AT CLARKSBURG
`
`MERCK SHARP & DOHME CORP,
`
`Plaintiff,
`
`C.A. No. 1:19-cv-101 (IMK)
`
`v.
`
`MYLAN PHARMACEUTICALS INC.,
`
`Defendant.
`
`STIPULATION AND ORDER REGARDING INFRINGEMENT
`
`Plaintiff Merck Sharp & Dohme Corp. (“Merck”) and Defendant Mylan Pharmaceuticals
`
`Inc. (“Mylan”) hereby STIPULATE, and request that the Court ORDER, as follows:
`
`1.
`
`With respect to Mylan’s ANDA Nos. 202473 and 202478, for purposes of
`
`this action, Mylan stipulates to infringement of claims 1, 2, and 19 of U.S. Patent No. 7,326,708
`
`(“the ’708 patent”), provided that the claim at issue remains asserted at trial and is not proven
`
`invalid at trial;
`
`2.
`
`Nothing in this stipulation precludes Mylan from pursuing any other
`
`defenses, including contesting the validity of any of claims 1, 2, or 19 of the ’708 patent;
`
`3.
`
`With respect to Mylan’s ANDA Nos. 202473 and 202478, for purposes of
`
`this action, Plaintiff will not assert infringement of claims 4-18 or 20-24 of the ’708 patent;
`
`4.
`
`The parties make this stipulation without prejudice to or waiver of their
`
`rights on any appeal of any judgment of this Court, except with respect to the matters of
`
`
`
`Case 1:19-cv-00101-IMK Document 152 Filed 12/10/21 Page 2 of 3 PageID #: 9077
`
`infringement as stipulated herein. The parties also make this stipulation without prejudice to or
`
`waiver of their rights with respect to IPR2020-00040 and any appeal thereof;
`
`5.
`
`This stipulation cannot be used for any other proceeding or for any other
`
`purpose except as expressly stipulated herein, including to argue that any other patent claims are
`
`infringed.
`
` Respectfully submitted,
`
`STEPTOE & JOHNSON, PLLC
`
`/s/ Gordon H. Copland
`Gordon H. Copland (WV Bar #828)
`William J. O’Brien (WV Bar #10549)
`400 White Oaks Blvd.
`Bridgeport, WV 26330
`(304) 933-8000
`gordon.copland@steptoe-johnson.com
`william.obrien@steptoe-johnson.com
`
`
`OF COUNSEL:
`
`Deepro R. Mukerjee (admitted PHV)
`Lance A. Soderstrom (admitted PHV)
`KATTEN MUCHIN ROSENMAN
`575 Madison Avenue
`New York, NY 10022
`(212) 940-8800
`deepro.mukerjee@kattenlaw.com
`lance.soderstrom@kattenlaw.com
`Jitendra Malik (admitted PHV)
`Joseph M. Janusz (admitted PHV)
`KATTEN MUCHIN ROSENMAN
`550 S. Tryon Street
`Suite 2900
`Charlotte, NC 28202
`(704) 344-3182
`alissa.pacchioli@kattentlaw.com
`jitty.malik@kattenlaw.com
`joe.janusz@kattenlaw.com
`
`IT IS HEREBY STIPULATED:
`
`Dated: December 10, 2021
`
`CAREY, DOUGLAS, KESSLER & RUBY, PLLC
`
`/s/ Steven R. Ruby
`Michael W. Carey (WVSB # 635)
`Steven R. Ruby (WVSB #10752)
`901 Chase Tower, 707 Virginia Street, East
`P.O. Box 913
`Charleston, WV 25323
`Telephone: (304) 345-1234
`Facsimile: (304) 342-1105
`sruby@cdkrlaw.com
`
`OF COUNSEL:
`
`Bruce R. Genderson (admitted PHV)
`Jessamyn S. Berniker (admitted PHV)
`Stanley E. Fisher (admitted PHV)
`Alexander S. Zolan (admitted PHV)
`Shaun P. Mahaffy(admitted PHV)
`Anthony H. Sheh (admitted PHV)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`T: (202) 434-5000
`F: (202) 434-5029
`bgenderson@wc.com
`jberniker@wc.com
`sfisher@wc.com
`azolan@wc.com
`smahaffy@wc.com
`asheh@wc.com
`
`
`
`
`
`
`
`2
`
`
`
`Case 1:19-cv-00101-IMK Document 152 Filed 12/10/21 Page 3 of 3 PageID #: 9078
`
`Counsel for Plaintiff
`Merck Sharp & Dohme Corp.
`
`Counsel for Defendant
`Mylan Pharmaceuticals Inc.
`
`IT IS SO ORDERED this 10th day of December, 2021.
`
`____________________________________
`UNITED STATES DISTRICT JUDGE
`
`3
`
`